The aim of this study was to compare measured LDL-C with LDL-C as calculated by the Friedewald, Martin/Hopkins, Vujovic, and Sampson formulas with regard to triglyceride (TG), LDL-C and non-high-density lipoprotein cholesterol (non-HDL-C)/TG ratio. Methods The 1,209 calculated LDL-C ...
Establishing cut-off values for apolipoprotein B and non-HDL-C according to LDL-C values in a South European population Summary Background: Low-density lipoprotein cholesterol (LDL-C) remains the primary target of therapy in most strategies of dyslipidaemia management focuse... S.,Martinez-Hervas...
Using this definition, RC is the cholesterol content of all non-LDL and non-HDL and can easily be calculated from a standard lipid profile as total cholesterol (TC) minus LDL-C minus high-density lipoprotein cholesterol (HDL-C). This method can be used without extra cost in patients ...
Two apoB100-predicting equations were compared in 87 type 2 diabetes mellitus (T2DM) patients using theDiscriminant ratio(DR).Equation 1: apoB100=0.65*non-high-density lipoprotein cholesterol+6.3; andEquation 2: apoB100=33.12+0.675*LDL-C+11.95*ln[triglycerides]. Theunderlyingbetween-subject ...
The aim of this study was to compare measured LDL-C with LDL-C as calculated by the Friedewald, Martin/Hopkins, Vujovic, and Sampson formulas with regard to triglyceride (TG), LDL-C and non-high-density lipoprotein cholesterol (non-HDL-C)/TG ratio.Cwiklinska, AgnieszkaWieczorek, EwaGliwin...
The high D-sdLDL-C enhanced risk of high LDL-C, non-HDL-C, and apoB (HR 1.73, 95%CI 1.27-2.37). Conclusions: High D-sdLDL-C can predict long-term recurrence of CAD in stable CAD patients independently of apoB and non-HDL-C by distinguishing the patients at high risk. D-sdLDL-...
Non-HDL cholesterolRemnant cholesterolObjectivesIncreased prevalence of pediatric obesity and associated co-morbidities has heightened the concern for cardiovascular disease (CVD) risk later in life. Although the fasting lipid profile is traditionally used to assess CVD risk, the non-fasting lipid profile...
The total cholesterol to high-density lipoprotein cholesterol (TC/HDL-C) ratio, estimated low-density lipoprotein cholesterol (LDL-C), and non-HDL-C are ro... MB Elshazly,R Quispe,ED Michos,... - 《Circulation》 被引量: 18发表: 2015年 Risk-adjusted comparison of blood pressure and low...
The similar trend was also found in both DM and non‐ DM patients comparing with different TG groups. However, in patients with DM, there was no significant difference of DV in different HbA1c groups or HDL ‐C concentrations ( P? > ? .05). Conclusion Although F‐ LDL might ...
Table 4 Change in total cholesterol, triglyceride, and HDL cholesterol in 72 patients treated with Alirocumab or Evolocumab Full size table Fig. 1 Median and 25th and 75th percentile LDLC (mg/dl) at study entry and 4, 12, and 24 weeks follow-up on Alirocumab 75 mg every two weeks Full ...